Schedule 13G ownership disclosure
Lomond Therapeutics Holdings, Inc.
Common Stock · CUSIP: 54173L101
Event date: 2025-03-24
- Filing-level shares
- 2,500,000.00
- Percent of class
- 7.76%
- Qatar Investment Authority
Shares: 2,500,000.00 · Class: 7.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-028297
- Form type
- SCHEDULE 13G
- Filer
- Lomond Therapeutics Holdings, Inc.
- CIK
- CIK 1900520
- Filed
- Mar 26, 2025
- Reporting period
- Mar 24, 2025
- Description
- Schedule 13G beneficial ownership